AL Amyloidosis and Anti-CD38-Daratunumab
Not Applicable
Completed
- Conditions
- Amyloidosis
- Registration Number
- NCT06571864
- Lead Sponsor
- University of Turin, Italy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients affected by AL amyloidosis<br><br> - Patients who were ineligible for high dose therapy and bone marrow transplantation<br> due to age and/or frailty score.<br><br>Exclusion criteria:<br><br> - Diagnosis of AL amyloidosis not biospy proven
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method organ responses were defined according to the updated International Society of Amyloidosis criteria
- Secondary Outcome Measures
Name Time Method